Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients

Clinical trial NCT00471965 · COMPLETED

Trial details

NCT number: NCT00471965
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2007-03-01
Primary completion: 2010-03-01
Enrollment: 371

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.